Skip to search formSkip to main contentSkip to account menu

Neoplasm, Residual

Known as: Minimal Residual Disease, Neoplasm, Residual [Disease/Finding], Residual Neoplasm 
Remnant of a tumor or cancer after primary, potentially curative therapy. (Dr. Daniel Masys, written communication)
National Institutes of Health

Related topics

Related topics

12 relations
Blood supply aspectsIn BloodMicrobiologicalProcess of secretion

Broader (1)

Malignant Neoplasms

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation Is Safe, Effective, and Leads to MRD-Negative…
BACKGROUND: Ivosidenib (AG-120) and enasidenib (AG-221) are oral inhibitors of mutant IDH1 (mIDH1) and mutant IDH2 (mIDH2… 
Highly Cited
2013
Highly Cited
2013
Bcl-2 Inhibitor ABT-199 (GDC-0199) Monotherapy Shows Anti-Tumor Activity Including Complete Remissions In High-Risk Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic…
Introduction Novel agents are needed for CLL/SLL patients (pts) R/R to standard therapies. The intrinsic apoptotic pathway is… 
Highly Cited
2009
Highly Cited
2009
Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
PURPOSE Minimal residual disease (MRD) is predictive of clinical progression in mantle-cell lymphoma (MCL). According to the… 
Highly Cited
2007
Highly Cited
2007
Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.
In patients with chronic myeloid leukemia, the use of real-time quantitative reverse transcription-polymerase chain reaction (qRT… 
Highly Cited
2003
Highly Cited
2003
Minimal residual disease in chronic myeloid leukemia.
For many years hematologists have used the microscope to identify a complete remission of leukemia after treatment with… 
Highly Cited
1999
Highly Cited
1999
Clonal rearrangements in childhood and adult precursor B acute lymphoblastic leukemia: a comparative polymerase chain reaction study using multiple sets of primers
Abstract: Ig heavy chain (IgH) and T‐cell receptor (TCR) gene rearrangements were investigated by polymerase chain reaction (PCR… 
Highly Cited
1996
Highly Cited
1996
Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation.
In B-cell non-Hodgkin's lymphoma (NHL), as in other B-cell malignancies, clonal rearrangement of the third complementarity… 
Highly Cited
1994
Highly Cited
1994
A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia
Summary. We have sought to determine whether peripheral blood or bone marrow is more sensitive for assessment of minimal residual… 
Highly Cited
1987
Highly Cited
1987
Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease.
In a rat model (BNML) for human acute myelocytic leukemia the distribution of leukemic cells in bone marrow samples from various… 
Highly Cited
1974
Highly Cited
1974
Insulin effects on brain energy metabolism and the related hexokinase distribution.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)